Home Biosimilar Antibodies Immunology & Inflammation Immunology & Inflammation related antibody Nurulimab (Anti-CTLA-4 / CD152) For research use only.
Not for use in humans.

Nurulimab (Anti-CTLA-4 / CD152)

Synonyms: null

Nurulimab (Anti-CTLA-4 / CD152) is a monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4, CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.34 KD.

Nurulimab (Anti-CTLA-4 / CD152)

Purity & Quality Control

Choose Selective Immunology & Inflammation related Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Nurulimab (Anti-CTLA-4 / CD152) is a monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4, CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.34 KD.

Product Details

CAS No. 2168561-20-2
Molecular Weight 145.34
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Nurulimab (Anti-CTLA-4 / CD152) | Nurulimab (Anti-CTLA-4 / CD152) supplier | purchase Nurulimab (Anti-CTLA-4 / CD152) | Nurulimab (Anti-CTLA-4 / CD152) cost | Nurulimab (Anti-CTLA-4 / CD152) manufacturer | order Nurulimab (Anti-CTLA-4 / CD152) | Nurulimab (Anti-CTLA-4 / CD152) distributor